http://www.lundbeck.com
Name of Scientific / Technical Leader: Dr Claus Stie Kallesøe,
Key individuals: Dr Claus Stie Kallesøe is Chief Specialist and head of Research Informatics. Claus Stie Kallesøe has been working with data management and informatics in Pharma research since 2000. Claus finalised his MSc (pharm) in 1997 with a thesis in synthetic medicinal chemistry and was then engaged at H. Lundbeck A/S as section head of the compound management group and in 2000 appointed Head of Department of Discovery Informatics. From 2003 to 2005 Claus also held a position as Executive Assistant to SVP of Research. The informatics group at Lundbeck mainly use open source tools for their in house development and the group promotes the sharing of tools and ideas. Claus is also engaged in several pre-competitive activities. He was PM for the 2nd round of IMI knowledge management calls leading to the current OpenPhacts project, he holds a seat in the PRISME forum and on the Board of Directors of the Pistoia Alliance. Claus also holds a Diploma in Software Development and an E-MBA from INSEAD in France. Birgitte Søgaard Worked for Pharmacia and Novo Nordisk A/S and is now Divisional Director – Clinical & Quantitative Pharmacology, H. Lundbeck A/S Has worked with Clinical Pharmacology for 25 years with focus on the establishment of biological models to be able to quantify and describe biological responses to support drug development. This includes biometrikser development within a number of therapeutic areas. Focus is on building PHC into drug development. Is a member of scientific advisory boards for a number of companies. Jennifer Larsen is currently employed as a Project Leader in Corporate Project Management and is leading a project dedicated to identification and development of blood biometriksers for Mood Disorders using omics technologies. Jennifer completed a PhD in Medicine (Neuroscience) in 2000 from Memorial University of Newfoundland with a thesis in Stroke investigating endogenous and pharmacological neuroprotective mechanisms. She was employed as a Post-Doctoral Fellow from 2000-2005 at the University of Calgary where she was involved in Spinal Cord Injury Research, both basic and clinical. Jennifer joined Lundbeck in 2005 as an in vivo pharmacologist and then subsequently joined the Translational Medicine Department on its inception in 2007. In this role, she was part of the team that created the infrastructure for biobanking of human clinical samples including sample collection, storage, tracking and use as well as the development of the clinical data repository for storage of data generated from translational research activities. In addition, she has been involved in several internal and external translational medicine initiatives including P1Vital and NEWMEDS.
Role in/ Contribution to the Consortium: WP contributions in WP 2: Platform Development, WP4: Analytics Research & Content Curation, WP5: Governance and Business Models, WP 6: Community Engagement & Outreach.
Expertise: Knowledge management; Technology & innovation management; Open source; Behavioural neuroscience; In vivo pharmacology; Translational research; Experimental design, Conduct and interpretation of data; Bridging disciplines.